Industry News

EMD Millipore receives recertification of GMP compliance for Biodevelopment Centre in Martillac, France.

Catalent appoints David Heyens as President of Asia Pacific facility.

Cargill invests to upgrade its alginate production plant in in Lannilis, Brittany, France.

VWR International has signed a global distribution agreement with Thermo Fisher Scientific.

Horizon Pharma reports that FDA has approved the use of Sanofi's manufacturing site in Compiegne, France to manufacture DUEXIS.

Myriad Genetics and AstraZeneca expand their companion diagnostic pact for AztraZeneca?s investigational drug candidate olaparib.

Mylan completes expansion of its transdermal patch facility in Vermont.

Sanofi and POZEN sign a license agreement for the commercialization of omeprazole and aspirin combination product.

Rockwell Collins will sell Kaiser Optical Systems to Endress+Hauser.

Meda will acquire Acton Pharmaceuticals.

BioReliance opens Clearance Services Laboratories in Maryland for downstream bioprocessing studies.

Endo will acquire Boca Pharmacal in multimillion dollar deal.

Agilent Technologies opens multimillion dollar Spectroscopy Technology Innovation Center in Australia.

CordenPharma will acquire Peptisyntha SA, based in Belgium.

FDA approves BD Simplist product ondansetron injection, an injectable antiemetic.

Zealand will join efforts with Eli Lilly to design and develop therapeutic peptides for Type 2 diabetes and obesity.

CEO of Waters Corporation will retire within in the next two years.

Baxter and Coherus Biosciences colaborate to develop and commercialize a biosimilar version of etanercept for Europe, Canada, and, Brazil.

Sobi's application for Orfadin oral suspension has been validated by EMA.

Hospira has initiated a voluntary nationwide user-level recall of Aminosyn II, due to a foreign particle included in the injection port.

BioReliance updates Big Blue Mouse Assay service to meet OECD test requirements.

The new director general has stepped into the European generic and biosimilar medicines industries at a challenging time when the trade association is facing numerous priority issues on the European agenda.

Akebia appoints new president and CEO.

Johnson & Johnson completes acquisition deal with Aragon Pharmaceuticals.

Pharmaceutical Product Development has acquired patient-recruitment contractor Acurian.

ATCC creates Biomaterial Contributor Network to assist the research community.

James Stewart named CIO of Merck KGaA.

Amarin released the submission of an sNDA to FDA seeking approval for Novasep Group.

The Russian pharmaceutical company PharmaStand finalizes deal for acquiring Bever, a Singapore pharma company.

Sangamo BioSciences has agreed to acquire Ceregene, a privately held biotechnology company focused on developing adeno-associated virus (AAV) gene therapies.